45 research outputs found
The Higgs Boson and the Cosmos
The Higgs boson is a cornerstone of the standard model (SM) of particle physics, thus it comes as no surprise that the announcement of its discovery on July 2012 by ATLAS and CMS marked a very important date for particle physics. All the pieces of the SM have finally been observed and the parameters of the theory measured. However, we know that the SM is far from a complete theory and the fact that the Higgs boson has been, up to date, the only discovery of the LHC may be seen as unfortunate by many. In fact, the LHC is just confirming with exceptional accuracy the predictions of the SM, pushing the scale of new physics to larger and larger values,
giving us no hints about its correct extension.
Having measured all the parameters of the SM we can assume its validity to an arbitrarily high energy scale and extrapolate its behavior using the renormalization group equations. It turns out that the value of the Higgs mass is low enough to allow this extrapolation and the SM remains consistent up to the Planck scale. However, this computation reveals yet another puzzle: our universe does not lie in the global minimum of the Higgs potential; instead a much deeper vacuum exists at large field values. In principle, quantum tunneling into the true vacuum is possible but fortunately the decay time is much longer than the age of our universe. For all practical purposes our vacuum is not in danger and the decay will not happen any time soon. This peculiar situation is called metastability.
Since the decay time is very long, new physics modifying the Higgs potential at high energies is not needed. The situation, however, changes dramatically if we want to understand why the Higgs ended up in such an energetically disfavored state in the framework of big bang cosmology. It is clear that some sort of fine-tuning is required in order to put the Higgs in the false vacuum. Not only that: the evolution of the universe goes through violent periods, such as inflation and reheating, where the Higgs may experience large fluctuations, making it difficult to justify why it did not decay into the true vacuum without assuming the existence of physics beyond the SM (BSM).
The Higgs is a natural window into particles which are not part of the SM. In fact, it is the only particle with spin-0 and the only field which can form a dimension-2 gauge and Lorentz invariant operator. Within the SM this property is used to write a mass term for the Higgs which generates spontaneous breaking of the electroweak symmetry, while in BSM models it allows to write interaction terms at the renormalizable level with gauge singlets and with gravity. In this thesis and in the papers attached we explore the effects that these renormalizable BSM operators have on the Higgs dynamics in the early universe. We show that stabilization of the Higgs field can be obtained in models of inflation if we allow the existence of Higgs-inflaton couplings or non-minimal coupling with gravity. The same models are then studied at the reheating stage, when all the particles that compose the present day universe are produced. On the other hand,
we also explore the possibility that the Higgs mixes with the inflaton. The mixing can stabilize the Higgs potential at all energies and generates two scalar eigenstates. The lighter one is identified with the boson discovered in 2012 and the other could be observed at the LHC or at future colliders
Higgs-Inflaton Mixing and Vacuum Stability
The quartic and trilinear Higgs field couplings to an additional real scalar are renormalizable, gauge and Lorentz invariant. Thus, on general grounds, one expects such couplings between the Higgs and an inflaton in quantum field theory. We find that the often omitted trilinear interaction is only weakly constrained by cosmology and could stabilize the electroweak vacuum by increasing the Higgs self coupling. The consequent Higgs-inflaton mixing can be as large as order one making a direct inflaton search possible at the LHC. (C) 2018 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license.Peer reviewe
Higgs-inflaton coupling from reheating and the metastable Universe
Current Higgs boson and top quark data favor metastability of our vacuum which raises questions as to why the Universe has chosen an energetically disfavored state and remained there during inflation. In this Letter, we point out that these problems can be solved by a Higgs-inflaton coupling which appears in realistic models of inflation. Since an inflaton must couple to the Standard Model particles either directly or indirectly, such a coupling is generated radiatively, even if absent at tree level. As a result, the dynamics of the Higgs field can change dramatically. (C) 2015 The Authors. Published by Elsevier B.V.Peer reviewe
A novel KPC-3 variant associated with CAZ/AVI resistance in a Klebsiella Ppneumoniae ST512 causing bacteremia
Imprinted antibody responses against SARS-CoV-2 Omicron sublineages
SARS-CoV-2 Omicron sublineages carry distinct spike mutations and represent an antigenic shift resulting in escape from antibodies induced by previous infection or vaccination. We show that hybrid immunity or vaccine boosters result in potent plasma neutralizing activity against Omicron BA.1 and BA.2 and that breakthrough infections, but not vaccination-only, induce neutralizing activity in the nasal mucosa. Consistent with immunological imprinting, most antibodies derived from memory B cells or plasma cells of Omicron breakthrough cases cross-react with the Wuhan-Hu-1, BA.1 and BA.2 receptor-binding domains whereas Omicron primary infections elicit B cells of narrow specificity. While most clinical antibodies have reduced neutralization of Omicron, we identified an ultrapotent pan-variant antibody, that is unaffected by any Omicron lineage spike mutations and is a strong candidate for clinical development
Imprinted antibody responses against SARS-CoV-2 Omicron sublineages
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron sublineages carry distinct spike mutations resulting in escape from antibodies induced by previous infection or vaccination. We show that hybrid immunity or vaccine boosters elicit plasma-neutralizing antibodies against Omicron BA.1, BA.2, BA.2.12.1, and BA.4/5, and that breakthrough infections, but not vaccination alone, induce neutralizing antibodies in the nasal mucosa. Consistent with immunological imprinting, most antibodies derived from memory B cells or plasma cells of Omicron breakthrough cases cross-react with the Wuhan-Hu-1, BA.1, BA.2, and BA.4/5 receptor-binding domains, whereas Omicron primary infections elicit B cells of narrow specificity up to 6 months after infection. Although most clinical antibodies have reduced neutralization of Omicron, we identified an ultrapotent pan-variant–neutralizing antibody that is a strong candidate for clinical development
Immune stealth-driven O2 serotype prevalence and potential for therapeutic antibodies against multidrug resistant Klebsiella pneumoniae
Emerging multidrug-resistant bacteria are a challenge for modern medicine, but how these pathogens are so successful is not fully understood. Robust antibacterial vaccines have prevented and reduced resistance suggesting a pivotal role for immunity in deterring antibiotic resistance. Here, we show the increased prevalence of Klebsiella pneumoniae lipopolysaccharide O2 serotype strains in all major drug resistance groups correlating with a paucity of anti-O2 antibodies in human B cell repertoires. We identify human monoclonal antibodies to O-antigens that are highly protective in mouse models of infection, even against heavily encapsulated strains. These antibodies, including a rare anti-O2 specific antibody, synergistically protect against drug-resistant strains in adjunctive therapy with meropenem, a standard-of-care antibiotic, confirming the importance of immune assistance in antibiotic therapy. These findings support an antibody-based immunotherapeutic strategy even for highly resistant K. pneumoniae infections, and underscore the effect humoral immunity has on evolving drug resistance